Sign inJoin waitlistJoin the waitlist

Hiram Gay

Chief, Genitourinary Service · Washington University/B-JH/SLCH Consortium

Credentials: · · · · ·

History

Genitourinary Service Division · Washington University/B-JH/SLCH Consortium
Present
Washington University/B-JH/SLCH Consortium
Present
Genitourinary Service Division · Washington University School of Medicine
Present

Radiation Oncology
SUNY Upstate Medical University
Chief ResidentUntil 2005
2001–2005
Preliminary or Transitional Year
2000–2001
University of Puerto Rico School of Medicine
1996–2000
University of Puerto Rico, Mayaguez, Puerto Rico (1996
1992–1996

Research

Radiation dose-volume effects in radiation-induced rectal injury
Review · International journal of radiation oncology · 2010 · 561 citations
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
International journal of radiation oncology · 2012 · First of 22 authors · Corresponding · 431 citations
Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image…
International journal of radiation oncology · 2015 · 368 citations

Jeff Michalski
62 papers
Wade Thorstad
59 papers
Douglas Adkins
36 papers
BB
Brian Baumann
33 papers · 3 as a resident
Benjamin Fischer-Valuck
28 papers · 14 as a resident
Jason Rich
23 papers
Mackenzie Daly
21 papers
Peter Oppelt
21 papers
RB
Randall Brenneman
21 papers · 16 as a resident
Ryan Jackson
21 papers · 1 as a fellow
Randal Paniello
19 papers
BN
Brian Nussenbaum
18 papers

Clinical trials

A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
Principal investigator · Active not recruiting · Phase 2
RTOG Foundation, Inc.
2019–2029
Pulsed Abraxane and Radiotherapy for Improving and Maintaining Ambulation After Cancer-Related Cord Compression
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2019–2021
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
Principal investigator · Recruiting · Phase 1, Phase 2
Washington University School of Medicine
2018–2030
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2024–2031